GenapSys is another success out of the Stanford StartX program, this one in the life sciences arena and part of the new StartX Med focus. Genapsys is developing an "easy-to-use genomic diagnostic system based on our simple label-free proprietary GENIUS™ technology". GenapSys is interesting because the CEO is a multi-disciplinary problem innovator combining research insights from both Electrical Engineering and the Genome Center (see detail below, which you can get to by clicking the H. Esfandyarpour orange dot and click Navigate to ... Open in Navigator).
I'd also like to note that Dr. Esfandyarpour's thesis advisor team included Prof. R. Fabian Pease, and we expected new outcomes from this hotspot as mentioned in a previous post.
